CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 

Amgen Inc 's Long Term Debt to Equity

AMGN's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




AMGN Long Term Debt to Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -55.54 % -70.67 % -90.19 % -28.79 % -25.02 %
Y / Y Long Term Debt Change 11.62 % 25.47 % 15.68 % 0.99 % -2.65 %
Long Term Debt to Equity MRQ 10.17 14.76 39.31 4.96 4.05
Overall Ranking # 2636 # 0 # 0 # 1215 # 2781
Seq. Equity Change 51.01 % 164.08 % -86.33 % -18.46 % -0.36 %
Seq. Long Term Debt Change 4.08 % -0.85 % 8.39 % -0.21 % 16.98 %



Long Term Debt to Equity third quarter 2022 Comment
In Spite of the net new long-term borrowings of 4.08% Amgen Inc managed to improve Long Term Debt to Equity in the third quarter 2022 to 10.17, above company's average Long Term Debt to Equity.

Within Biotechnology & Pharmaceuticals industry in the third quarter 2022, 96 other companies have achieved lower Long Term Debt to Equity than Amgen Inc . While Long Term Debt to Equity total ranking has deteriorated compare to the previous quarter from 0 to 2636.

Explain Long Term Debt to Equity Ratio?
Learn more about AMGN
Long Term Debt to Equity Ratio AMGN on the trailing twelve month basis
Long Term Debt to Equity third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 97
Healthcare Sector # 389
Overall Market # 2636


Long Term Debt to Equity Statistics
High Average Low
39.31 1.93 0.01
(Mar 31 2022)   (Sep. 30, 2004)




Financial Statements
Amgen Inc 's Equity $ 3,653 Millions Visit AMGN's Balance sheet
Amgen Inc 's Long Term Debt $ 37,161 Millions Visit AMGN's Balance sheet
Source of AMGN's Sales Visit AMGN's Sales by Geography


Cumulative Amgen Inc 's Long Term Debt to Equity

AMGN's Long Term Debt to Equity for the trailling 12 Months

AMGN Long Term Debt to Equity

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -55.54 % -70.67 % -90.19 % -28.79 % -25.02 %
Y / Y Long Term Debt TTM Growth 11.62 % 25.47 % 15.68 % 0.99 % -2.65 %
Long Term Debt to Equity TTM 10.38 7.57 5.44 3.88 3.57
Total Ranking TTM # # # # #
Seq. Equity TTM Growth 51.01 % 164.08 % -86.33 % -18.46 % -0.36 %
Seq. Long Term Debt TTM Growth 4.08 % -0.85 % 8.39 % -0.21 % 16.98 %


TTM Long Term Debt to Equity Comment
On the trailing twelve months basis Due to net new long-term borrowings of 4.08%, Long Term Debt to Equity improved to 10.38, above Amgen Inc 's average Long Term Debt to Equity.
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry AMGN recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Long Term Debt to Equity Ratio?
Learn more about AMGN
Long Term Debt to Equity Ratio AMGN on the trailing twelve month basis

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market # 0


TTM Long Term Debt to Equity Statistics
High Average Low
1.27 0.52 0.11
(Sep. 30, 2014)   (Dec. 31. 2005)




Companies with similar Long Term Debt to Equity in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Long Term Debt to EquitySep 30 2022 MRQ Long Term DebtSep 30 2022 MRQ Equity
Halozyme Therapeutics Inc   15.37 $ 1,491.156  Millions$ 96.991  Millions
Achieve Life Sciences Inc   15.10 $ 15.763  Millions$ 1.044  Millions
Amgen Inc   10.17 $ 37,161.000  Millions$ 3,653.000  Millions
Fennec Pharmaceuticals Inc   8.81 $ 24.688  Millions$ 2.802  Millions
Gamida Cell Ltd   5.31 $ 71.999  Millions$ 13.561  Millions
Invacare Corporation  4.11 $ 333.129  Millions$ 81.045  Millions
Taysha Gene Therapies Inc   3.40 $ 37.773  Millions$ 11.126  Millions
Pactiv Evergreen Inc   2.86 $ 4,202.000  Millions$ 1,467.000  Millions
Nanostring Technologies Inc   2.73 $ 226.250  Millions$ 82.928  Millions
Acorda Therapeutics inc   2.48 $ 187.689  Millions$ 75.766  Millions
Rubius Therapeutics Inc   2.10 $ 76.829  Millions$ 36.587  Millions

Date modified: 2022-11-06T23:41:51+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CSWI's Profile

Stock Price

CSWI's Financials

Business Description

Fundamentals

Charts & Quotes

CSWI's News

Suppliers

CSWI's Competitors

Customers & Markets

Economic Indicators

CSWI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071